| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/06/2005 | US20050003347 Protein fusion comprised of heavy chain with variable region, constant region, multivalent binding surface comprised of two conventional antigen binding sites and at least one non-conventional binding site formed by an interface between adjacently positioned heavy chain variable regions |
| 01/06/2005 | US20050003346 Using phage amplification and mass spectroscopy to detect microorganismal infection |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | US20050003343 Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents |
| 01/06/2005 | US20050003339 Method of detecting ps2v |
| 01/06/2005 | US20050003187 Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media |
| 01/06/2005 | US20050003051 Freshness indicator; fermentation of yeast, bacteria in radiation transparent vessel; generating a gas; measurement; calibration; cell proliferation indicator |
| 01/06/2005 | US20050002985 Device with recessed tracks for forming a cellular network |
| 01/06/2005 | US20050002960 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002959 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002947 Screening candidate anthelmintic materials for immobilization and toxicity activity |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002940 Cancerous disease modifying antibodies |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002934 Recombinant IL-9 antibodies and uses thereof |
| 01/06/2005 | US20050002933 Proliferation and/or differentiation of stem and progenitor cells from embryo or adult |
| 01/06/2005 | US20050002917 Regulation of Acheron expression |
| 01/06/2005 | US20050002898 N-TRADD active site and uses thereof |
| 01/06/2005 | US20050002862 Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders |
| 01/06/2005 | US20050002827 Optical discs including equi-radial and/or spiral analysis zones and related disc drive systems and methods |
| 01/06/2005 | US20050002826 Apparatus and method for measuring immature platelets |
| 01/06/2005 | US20050002552 Automated in vitro cellular imaging assays for micronuclei and other target objects |
| 01/06/2005 | US20050001176 System, method, and product for providing a wavelength tunable excitation beam |
| 01/06/2005 | US20050000981 Apparatus and method for generating calibration gas |
| 01/06/2005 | US20050000829 Measuring electrophysical properties of sample; calibrating; computing variation |
| 01/06/2005 | US20050000809 Integrated flow passage |
| 01/06/2005 | US20050000807 Biosensor with multi-channel A/D conversion and a method thereof |
| 01/06/2005 | US20050000806 Biosensor for monitoring an analyte content with a partial voltage generated therefrom |
| 01/06/2005 | US20050000271 Modular gas measuring system |
| 01/06/2005 | US20050000270 Combustible Gas Detection System |
| 01/06/2005 | CA2848433A1 Screening methods |
| 01/06/2005 | CA2531033A1 Voltammetric detection of metabolites in physiological fluids |
| 01/06/2005 | CA2530300A1 System and method for determining an abused sensor during analyte measurement in a biological fluid |
| 01/06/2005 | CA2530184A1 Method of selecting patients suitable for wt1 vaccine |
| 01/06/2005 | CA2530130A1 Modulation of osteoblast activity by fhl2 |
| 01/06/2005 | CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 01/06/2005 | CA2528343A1 Modulating the interaction between hgf beta chain and c-met |
| 01/06/2005 | CA2528281A1 Methods for identifying agents, which regulate cytokines |
| 01/06/2005 | CA2528155A1 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 01/06/2005 | CA2528077A1 Methods for predicting the course of a malignant disease |
| 01/06/2005 | CA2527636A1 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | CA2527437A1 Screening methods |
| 01/06/2005 | CA2526898A1 Detection of protease-resistant prion protein following a spontaneous transformation reaction |
| 01/06/2005 | CA2526780A1 Pem-3-like compositions and related methods thereof |
| 01/06/2005 | CA2526023A1 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 01/06/2005 | CA2523583A1 Method and apparatus for sensing hydrogen gas |
| 01/05/2005 | EP1494031A2 Novel human genes and gene expression products |
| 01/05/2005 | EP1494030A2 Sample pretreatment solution for influenza virus test by immunochromatography |
| 01/05/2005 | EP1494029A1 Method of analyzing molecule and molecule analyzer |
| 01/05/2005 | EP1494028A1 Immunomagnetic separation of specific target cells |
| 01/05/2005 | EP1494026A1 Difference gel electrophoresis using matched multiple dyes |
| 01/05/2005 | EP1494022A2 Extended use planar sensors |
| 01/05/2005 | EP1494021A1 Analytical appliance cartridge with retrieval mechanism, and set of the cartridge and analyzer |
| 01/05/2005 | EP1494000A1 Method of marking a material with ions already comprised in said material and method of verifying the authenticity of said material |
| 01/05/2005 | EP1493995A1 Automated mass loading device for oedometer with frontal loading |
| 01/05/2005 | EP1493826A1 Container for carrying out and monitoring biological processes |
| 01/05/2005 | EP1493825A2 Method for producing nucleic acid ligands |
| 01/05/2005 | EP1493805A1 Cell culture system, apparatus for checking cultured cells and apparatus for culturing cells |
| 01/05/2005 | EP1493750A2 HCV regulated proteins |
| 01/05/2005 | EP1493749A1 Novel HCV core + 1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents |
| 01/05/2005 | EP1493439A1 Means of ascertaining an individual' s risk profile for atherosclerotic disease |
| 01/05/2005 | EP1493438A1 Vanilloid receptor (VR) inhibitors for treatment of Human Immunodeficiency Virus (HIV)-mediated pain states |
| 01/05/2005 | EP1493395A2 Control apparatus for an automated surgical biopsy device |
| 01/05/2005 | EP1493352A1 Set, especially for cosmetic, comprising an indicator or sensor for the ambiant moisture |
| 01/05/2005 | EP1493049A1 Method for detecting an analyte in a fluid |
| 01/05/2005 | EP1493035A1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell |
| 01/05/2005 | EP1493034A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2005 | EP1493033A2 Sc6 for diagnosis of hypoxia related conditions |
| 01/05/2005 | EP1493032A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 01/05/2005 | EP1493031A2 Active solid support and method for surface immobilization of combinatorial compounds or libraries |
| 01/05/2005 | EP1493029A2 Sensitive immunochromatographic assay |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1493027A2 Methods, systems, and software for identifying functional bio-molecules |
| 01/05/2005 | EP1493026A2 Device and method for controlling the composition of a gaseous atmosphere |
| 01/05/2005 | EP1493025A1 Apparatus for analyzing mixtures of gases |
| 01/05/2005 | EP1493016A2 Automated protein crystallization imaging |
| 01/05/2005 | EP1493015A1 Analyte sensor |
| 01/05/2005 | EP1493014A2 Multi-parameter assays including analysis discs and methods relating thereto |
| 01/05/2005 | EP1492945A1 Method and apparatus for controlling a gas-emitting process and related devices |
| 01/05/2005 | EP1492889A2 Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases |
| 01/05/2005 | EP1492887A1 Methods and devices for performing chemical reactions on a solid support |
| 01/05/2005 | EP1492885A2 Schizophrenia associated genes |
| 01/05/2005 | EP1492884A2 Methods of diagnosing and treating colorectal cancer |
| 01/05/2005 | EP1492883A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 01/05/2005 | EP1492882A1 Methods and reagents for assaying protein kinase activity |
| 01/05/2005 | EP1492881A2 Use of biological photoreceptors as directly light-activated ion channels |
| 01/05/2005 | EP1492880A1 Ex vivo method for determination of cetp activity and efficacy of heart disease treatment |
| 01/05/2005 | EP1492879A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
| 01/05/2005 | EP1492878A1 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 01/05/2005 | EP1492871A2 Cancer associated protein kinases and their uses |
| 01/05/2005 | EP1492869A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/05/2005 | EP1492867A2 Identification of virulence associated regions rd1 and rd5 enabling the development of imrpoved vaccines of m. bovis bcg and m. microti |
| 01/05/2005 | EP1492813A2 Ox40r binding agents |
| 01/05/2005 | EP1492812A2 Modulator of the notch signalling pathway and use thereof in medical treatment |
| 01/05/2005 | EP1492809A2 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity |
| 01/05/2005 | EP1492806A2 Human smooth muscle myosin heavy chain |
| 01/05/2005 | EP1492805A2 System for tracing animal products |
| 01/05/2005 | EP1492565A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |